Based on preceding screening of EGFR and HER3 expression in primary and metastatic NSCLC tumor tissue, the CTC detection method based on these two markers has been developed and exerted the possibility to capture a larger fraction of CTCs also in combination with EpCAM in NSCLC patients. The gene discussed is EPCAM; the disease is non-small cell lung carcinoma.